GlaxoSmithKline plc (NYSE: GSK) has reduced the minimum tender condition and extended its previously announced tender offer to purchase all ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE